Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
Wei-Fan HsuPei-Chein TsaiChi-Yi ChenKuo-Chih TsengHsueh-Chou LaiHsing-Tao KuoChao-Hung HungShui-Yi TungJing-Houng WangJyh-Jou ChenPei-Lun LeeRon-Nan ChienChun-Yen LinChi-Chieh YangGin-Ho LoChi-Ming TaiChih-Wen LinJia-Horng KaoChun-Jen LiuChen-Hua LiuSheng-Lei YanMing-Jong BairWei-Wen SuCheng-Hsin ChuChih-Jen ChenChing-Chu LoPin-Nan ChengYen-Cheng ChiuChia-Chi WangJin-Shiung ChengWei-Lun TsaiHan-Chieh LinYi-Hsiang HuangJee-Fu HuangChia-Yen DaiWan-Long ChuangMing-Lung YuCheng-Yuan PengPublished in: Journal of gastroenterology and hepatology (2021)
Hepatitis C virus eradication with PR therapy decreased the incidence of new-onset LC in noncirrhotic patients and the incidence of liver-related complications in cirrhotic patients with CHC.
Keyphrases
- hepatitis c virus
- risk factors
- human immunodeficiency virus
- end stage renal disease
- ejection fraction
- newly diagnosed
- helicobacter pylori infection
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- risk assessment
- helicobacter pylori
- mesenchymal stem cells
- patient reported outcomes
- liver fibrosis
- human health
- antiretroviral therapy